Page last updated: 2024-10-17

aminocaproic acid and Carcinosarcoma

aminocaproic acid has been researched along with Carcinosarcoma in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Carcinosarcoma: A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CLIFFTON, EE1
AGOSTINO, D1

Other Studies

1 other study available for aminocaproic acid and Carcinosarcoma

ArticleYear
EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
    Journal of the National Cancer Institute, 1964, Volume: 33

    Topics: Aminocaproates; Aminocaproic Acid; Blood; Carcinosarcoma; Enzyme Inhibitors; Fibrinolysin; Fibrinoly

1964